SGP: SpyGlass Pharma, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
52 institutions reported holding $566.12M of SpyGlass Pharma, Inc. on Form 13F (35 the quarter before). 22 opened a new position and 5 sold out. Shares held by institutions: +3%.
| Largest holders | Shares | Value |
|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 8,021,117 | $178.55M |
| NEA Management Company, LLC | 7,392,301 | $164.55M |
| Sands Capital Alternatives, LLC | 2,500,012 | $55.65M |
| SAMSARA BIOCAPITAL, LLC | 2,109,953 | $46.97M |
| BlackRock, Inc. | 711,712 | $15.84M |
| Vestal Point Capital, LP | 670,000 | $14.91M |
| JPMORGAN CHASE & CO | 629,739 | $13.63M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 550,000 | $12.24M |
| MILLENNIUM MANAGEMENT LLC | 507,257 | $11.29M |
| Aberdeen Group plc | 493,076 | $10.98M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.